This inventor holds 1 USPTO granted patent. Top assignee: Other. Active years: 1990.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1990
Title: The Innovations of Bengt K Gustafsson
Introduction
Bengt K Gustafsson is a notable inventor based in Bjarred, Sweden. He has made significant contributions to the field of neuropharmacology, particularly through his innovative work on 1-piperazinecarboxamide derivatives. His research focuses on developing compounds that can aid in the treatment of mental disorders, such as psychoses and depression.
Latest Patents
Gustafsson holds a patent for a series of novel 1-piperazinecarboxamide derivatives. These compounds are designed to serve as neuropharmacological agents, showcasing their potential in addressing various mental health issues. The patent highlights the unique formula of these derivatives, which is aimed at improving therapeutic outcomes for patients suffering from mental disorders.
Career Highlights
Throughout his career, Bengt K Gustafsson has demonstrated a commitment to advancing medical science through his innovative inventions. His work has not only contributed to the understanding of neuropharmacological agents but has also paved the way for new treatment options for mental health conditions. With a patent portfolio that includes 1 patent, he continues to be a valuable asset in the field of research and development.
Collaborations
Gustafsson has collaborated with esteemed colleagues, including Anders K Bjork and Knut G Olsson. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise, further enhancing the impact of their research.
Conclusion
Bengt K Gustafsson's contributions to neuropharmacology through his innovative patents highlight the importance of research in developing effective treatments for mental disorders. His work exemplifies the potential of scientific innovation to improve lives and advance medical knowledge.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile